Moderna begins trial of Omicron-specific vaccine booster – Times of India
[ad_1] WASHINGTON: US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of Covid-19. The trials will involve a…